High serum N-acetyl-ß-D-glucosaminidase activity is a predictor of 28-year mortality in a population of community-dwelling Japanese-The Tanushimaru study

Journal of the American Geriatrics Society

Volumn 61, Issue 3, 2013, Pages 467-468

  Yoshikawa, Kuniko ^a   Adachi, Hisashi ^a   Hirai, Yuji ^a   Enomoto, Mika ^a   Fukami, Ako ^a   Ogata, Kinuka ^a   Tsukagawa, Eri ^a   Kasahara, Akiko ^a   Yokoi, Kanako ^a   Okina, Norihito ^a   Obuchi, Aya ^a   Yoshimura, Ayako ^a   Nakamura, Sachiko ^a   Imaizumi, Tsutomu ^a  

^a not available

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; N ACETYL BETA GLUCOSAMINIDASE; TRIACYLGLYCEROL; URIC ACID;

AGED; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CAUSAL ATTRIBUTION; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COLORIMETRY; DEMENTIA; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INFECTION; JAPANESE; KIDNEY FUNCTION; LETTER; MAJOR CLINICAL STUDY; MALE; MORTALITY; SURVIVAL RATE;

EID: 84875132632     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.12083     Document Type: Letter

References (10)

1. Belfiore F, Napoli E, Vecchio LL, et al. Increased serum activity of beta-n-acetyl-glucosaminidase in atherosclerosis. Am J Med Sci 1974; 268: 235-239.
2. Simon G, Altman S,. Increased serum N-acetyl-beta-D-glucosaminidase activity in human hypertension. Clin Exp Hypertens A 1982; 4: 355-365.
3. Schmieder RE, Rockstroh JK, Münch HG, et al. Elevated serum activity of N-acetyl-beta-glucosaminidase in essential hypertension: Diagnostic value and reversal to normal values after antihypertensive therapy. Am J Kidney Dis 1991; 18: 638-648.
4. Hashimoto R, Adachi H, Nishida H, et al. Serum N-acetyl-beta-D- glucosaminidase activity in predicting the development of hypertension. Hypertension 1995; 25: 1311-1314.
5. Noto A, Ogawa Y, Mori S, et al. Simple, rapid spectrophotometry of urinary N-acetyl-beta-D-glucosaminidase, with use of a new chromogenic substrate. Clin Chem 1983; 29: 1713-1716.
6. Nomura G, Sakai S, Sumie M, et al. Serum N-acetyl-beta-D-glucosaminidase activity in a large population-a useful index of cardiovascular impairment. Jpn Circ J 1985; 49: 68-74.
7. Sundaram N, Bennett M, Wilhelm J, et al. Biomarkers for early detection of sickle nephropathy. Am J Hematol 2011; 86: 559-566.
8. Woynarowska B, Wikiel H, Bernacki RJ,. Human ovarian carcinoma ß-N-acetylglucosaminidase isoenzymes and their role in extracellular matrix degradation. Cancer Res 1989; 49: 5598-5604.
9. Severini G, Aliberti LM,. Serum N-acetylglucosaminidase activity in breast cancer. Cancer Biochem Biophys 1994; 14: 87-92.
10. Luqmani Y, Temmim L, Memon A, et al. Measurement of serum N-acetyl beta glucosaminidase activity in patients with breast cancer. Acta Oncol 1999; 38: 649-653.